US Stock MarketDetailed Quotes
LTRN Lantern Pharma
- 3.540
- -0.010-0.28%
Close Oct 15 16:00 ET
- 3.370
- -0.170-4.80%
Post 19:25 ET
38.11MMarket Cap-2145P/E (TTM)
3.600High3.420Low66.39KVolume3.500Open3.550Pre Close236.22KTurnover0.84%Turnover RatioLossP/E (Static)10.76MShares11.99052wk High1.23P/B28.12MFloat Cap2.38052wk Low--Dividend TTM7.94MShs Float24.840Historical High--Div YieldTTM5.07%Amplitude2.380Historical Low3.558Avg Price1Lot Size
Lantern Pharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -44.51%-5.19M | 18.33%-3.07M | -12.37%-14.35M | -26.85%-3.39M | 10.55%-3.61M | -31.45%-3.59M | -12.90%-3.76M | -20.54%-12.77M | -30.89%-2.67M | 13.76%-4.04M |
| Net income from continuing operations | -4.49%-4.96M | -40.67%-5.44M | -11.93%-15.96M | -23.80%-4.19M | -39.60%-3.16M | -5.65%-4.75M | 6.16%-3.87M | -15.34%-14.26M | 4.50%-3.38M | 44.14%-2.26M |
| Operating gains losses | -259.88%-56.58K | 31.66%100.27K | -32.09%127.34K | -66.63%-79.17K | -22.38%94.96K | -73.75%35.39K | 444.43%76.15K | 272.83%187.52K | -6,671.09%-47.51K | --122.35K |
| Depreciation and amortization | 21.28%4.26K | 18.81%4.06K | 44.98%14.62K | 44.02%3.98K | 25.92%3.71K | 47.21%3.51K | 71.85%3.42K | 49.11%10.08K | 38.62%2.76K | 59.56%2.95K |
| Other non cash items | 4.38%42.01K | 2.65%41.08K | 10.81%160.23K | 11.60%40.34K | 9.58%39.61K | 11.34%40.25K | 10.72%40.03K | 59.50%144.6K | -47.69%36.15K | 1,519.36%36.15K |
| Change In working capital | -144.40%-301.64K | 986.56%2.13M | 187.93%538.02K | 131.17%879.22K | 67.15%-780.24K | -39.32%679.39K | -191.16%-240.35K | -201.98%-611.86K | -61.08%380.34K | -173.92%-2.38M |
| -Change in prepaid assets | -271.55%-913.95K | 865.92%901.02K | 191.06%941.44K | -31.22%499.36K | 113.63%26.96K | 147.49%532.75K | 73.27%-117.64K | -5.01%-1.03M | 247.92%726.03K | 38.92%-197.76K |
| -Change in payables and accrued expense | 269.22%661.18K | 1,988.12%1.27M | -140.70%-236.18K | 237.39%419.92K | 64.08%-767.87K | -92.15%179.07K | -109.06%-67.3K | -64.22%580.36K | -120.54%-305.64K | -293.35%-2.14M |
| -Change in other current assets | -186.56%-6.15K | --0 | ---7.98K | --0 | --0 | --7.1K | ---15.08K | --0 | --0 | --0 |
| -Change in other current liabilities | -8.08%-42.73K | -1.38%-40.89K | -0.54%-159.26K | -0.02%-40.06K | 1.81%-39.33K | 0.16%-39.54K | -4.22%-40.33K | -121.06%-158.4K | 44.11%-40.05K | ---40.05K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -44.51%-5.19M | 18.33%-3.07M | -12.37%-14.35M | -26.85%-3.39M | 10.55%-3.61M | -31.45%-3.59M | -12.90%-3.76M | -20.54%-12.77M | -30.89%-2.67M | 13.76%-4.04M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 55.81%-202.06K | 42.12%-556.17K | -618.89%-930.21K | -57.51%256.18K | 411.61%231.73K | 13.03%-457.24K | -644.35%-960.88K | 100.92%179.27K | 357.68%602.86K | 92.58%-74.36K |
| Net PPE purchase and sale | ---4.27K | 75.02%-2.22K | 32.72%-18.73K | 26.94%-5.08K | 28.82%-4.78K | --0 | ---8.88K | -79.65%-27.84K | -695,400.00%-6.96K | -92.62%-6.71K |
| Net investment purchase and sale | 56.74%-197.8K | 41.81%-553.95K | -540.09%-911.48K | -57.16%261.26K | 449.59%236.51K | 10.62%-457.24K | -639.32%-952K | 101.06%207.11K | 360.65%609.82K | 93.23%-67.65K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 55.81%-202.06K | 42.12%-556.17K | -618.89%-930.21K | -57.51%256.18K | 411.61%231.73K | 13.03%-457.24K | -644.35%-960.88K | 100.92%179.27K | 357.68%602.86K | 92.58%-74.36K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 54.72K | 77.09%-500K | -500K | 0 | 0 | 0 | -103.44%-2.18M | 0 | 0 |
| Net common stock issuance | ---- | ---- | 79.86%-500K | ---500K | ---- | ---- | ---- | -103.60%-2.48M | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --54.72K | --0 | --0 | --0 | --0 | --0 | 114.73%299.79K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --54.72K | 77.09%-500K | ---500K | --0 | --0 | --0 | -103.44%-2.18M | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -44.40%18.36M | -41.88%21.94M | -28.14%37.74M | -35.75%25.57M | -34.03%28.96M | -30.03%33.02M | -28.14%37.74M | 173.15%52.52M | -28.51%39.8M | -28.44%43.9M |
| Current changes in cash | -33.18%-5.39M | 24.33%-3.57M | -6.81%-15.78M | -75.66%-3.63M | 17.80%-3.38M | -24.27%-4.05M | 11.54%-4.72M | -144.36%-14.77M | 34.32%-2.07M | 27.66%-4.11M |
| Effect of exchange rate changes | 276.19%11.32K | -97.27%-9.83K | -168.33%-28.46K | -148.61%-4.81K | -260.04%-12.24K | 78.89%-6.43K | -318.74%-4.98K | -1,091.31%-10.61K | 825.33%9.9K | --7.65K |
| End cash Position | -55.20%12.98M | -44.40%18.36M | -41.88%21.94M | -41.88%21.94M | -35.75%25.57M | -34.03%28.96M | -30.03%33.02M | -28.14%37.74M | -28.14%37.74M | -28.51%39.8M |
| Free cash flow | -44.63%-5.19M | 18.46%-3.07M | -12.27%-14.37M | -26.71%-3.39M | 10.58%-3.62M | -30.77%-3.59M | -13.17%-3.77M | -20.63%-12.8M | -31.23%-2.68M | 13.68%-4.04M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data